Insulet
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Insulet 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PODD
Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals.
CEOAshley A. McEvoy
CEOAshley A. McEvoy
Employees3,900
Employees3,900
HeadquartersActon, Massachusetts
HeadquartersActon, Massachusetts
Founded2000
Founded2000
Employees3,900
Employees3,900
PODD Key Statistics
Market cap24.06B
Market cap24.06B
Price-Earnings ratio102.85
Price-Earnings ratio102.85
Dividend yield—
Dividend yield—
Average volume590.33K
Average volume590.33K
High today$351.94
High today$351.94
Low today$336.00
Low today$336.00
Open price$337.75
Open price$337.75
Volume467.27K
Volume467.27K
52 Week high$353.50
52 Week high$353.50
52 Week low$225.28
52 Week low$225.28
PODD News
TipRanks 3d
Top Executives at Insulet Make Significant Stock Sales!New insider activity at Insulet ( (PODD) ) has taken place on September 9, 2025. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% of...
Simply Wall St 6d
Market Participants Recognise Insulet Corporation's Revenues Pushing Shares 26% HigherInsulet Corporation ( ) shareholders would be excited to see that the share price has had a great month, posting a 26% gain and recovering from prior weakness....
Analyst ratings
82%
of 28 ratingsBuy
82.1%
Hold
17.9%
Sell
0%
People also own
Based on the portfolios of people who own PODD. This list is generated using Robinhood data, and it’s not a recommendation.